Literature DB >> 7695256

Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis.

J L Martin1, C E Brown, N Matthews-Davis, J E Reardon.   

Abstract

Inhibition constants were determined for 16 nucleoside analog triphosphates against human DNA polymerases alpha, beta, gamma, and epsilon, and 7 nucleoside analogs were examined as inhibitors of mitochondrial DNA synthesis in human Molt-4 cells in culture. The results demonstrate no clear quantitative or qualitative correlation between inhibition of DNA polymerases, particularly mitochondrial DNA polymerase gamma, and the inhibition of mitochondrial DNA synthesis in Molt-4 cell culture. Furthermore, the data indicate that inhibition of isolated DNA polymerases may not be predictive of in vitro or in vivo toxicity. Finally, it is not clear whether inhibition of mitochondrial DNA synthesis will be an accurate predictor of the potential in vivo toxicity of antiviral nucleoside analogs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7695256      PMCID: PMC188279          DOI: 10.1128/AAC.38.12.2743

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  53 in total

1.  Human immunodeficiency virus reverse transcriptase: steady-state and pre-steady-state kinetics of nucleotide incorporation.

Authors:  J E Reardon
Journal:  Biochemistry       Date:  1992-05-12       Impact factor: 3.162

2.  Purification and identification of subunit structure of the human mitochondrial DNA polymerase.

Authors:  H Gray; T W Wong
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

3.  Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir.

Authors:  S C Stanat; J E Reardon; A Erice; M C Jordan; W L Drew; K K Biron
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

4.  Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.

Authors:  C H Chen; M Vazquez-Padua; Y C Cheng
Journal:  Mol Pharmacol       Date:  1991-05       Impact factor: 4.436

5.  Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study.

Authors:  T C Meng; M A Fischl; A M Boota; S A Spector; D Bennett; Y Bassiakos; S H Lai; B Wright; D D Richman
Journal:  Ann Intern Med       Date:  1992-01-01       Impact factor: 25.391

6.  The 5'-triphosphates of 3'-azido-3'-deoxythymidine and 2', 3'-dideoxynucleosides inhibit DNA polymerase gamma by different mechanisms.

Authors:  S Izuta; M Saneyoshi; T Sakurai; M Suzuki; K Kojima; S Yoshida
Journal:  Biochem Biophys Res Commun       Date:  1991-09-16       Impact factor: 3.575

7.  Ultrastructure of peripheral neuropathy induced in rabbits by 2',3'-dideoxycytidine.

Authors:  D Feldman; C Brosnan; T D Anderson
Journal:  Lab Invest       Date:  1992-01       Impact factor: 5.662

8.  Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-dideoxycytidine neurotoxicity.

Authors:  T D Anderson; A Davidovich; R Arceo; C Brosnan; J Arezzo; H Schaumburg
Journal:  Lab Invest       Date:  1992-01       Impact factor: 5.662

9.  Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine.

Authors:  C H Chen; Y C Cheng
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

10.  Structural relationships between two forms of DNA polymerase epsilon from calf thymus.

Authors:  G Siegal; J J Turchi; C B Jessee; L M Mallaber; R A Bambara; T W Myers
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

View more
  89 in total

1.  Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2'-deoxy-3'-oxa-4'-thiocytidine.

Authors:  J M de Muys; H Gourdeau; N Nguyen-Ba; D L Taylor; P S Ahmed; T Mansour; C Locas; N Richard; M A Wainberg; R F Rando
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Tenofovir diphosphate is a poor substrate and a weak inhibitor of rat DNA polymerases alpha, delta, and epsilon*.

Authors:  Gabriel Birkus; Miroslav Hájek; Pavel Kramata; Ivan Votruba; Antonín Holý; Berta Otová
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion.

Authors:  Tony Antoniou; Thea Weisdorf; Kevin Gough
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

4.  Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity.

Authors:  Edward E McKee; Alice T Bentley; Matthew Hatch; Joel Gingerich; Delia Susan-Resiga
Journal:  Cardiovasc Toxicol       Date:  2004       Impact factor: 3.231

5.  Bone disease in HIV infection.

Authors:  Maristella Francesca Saccomanno; Adriana Ammassari
Journal:  Clin Cases Miner Bone Metab       Date:  2011-01

6.  Enhanced oxidative stress and increased mitochondrial mass during efavirenz-induced apoptosis in human hepatic cells.

Authors:  N Apostolova; L J Gomez-Sucerquia; A Moran; A Alvarez; A Blas-Garcia; J V Esplugues
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

7.  Pre-steady-state kinetic analysis of the incorporation of anti-HIV nucleotide analogs catalyzed by human X- and Y-family DNA polymerases.

Authors:  Jessica A Brown; Lindsey R Pack; Jason D Fowler; Zucai Suo
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

Review 8.  Mitochondrial injury. Lessons from the fialuridine trial.

Authors:  P Honkoop; H R Scholte; R A de Man; S W Schalm
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

Review 9.  Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.

Authors:  Nila Bhana; Douglas Ormrod; Caroline M Perry; David P Figgitt
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

10.  Absence of a universal mechanism of mitochondrial toxicity by nucleoside analogs.

Authors:  Kaleb C Lund; LaRae L Peterson; Kendall B Wallace
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.